Flagship Pioneering’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.6M | Hold |
12,674,120
| – | – | 22.19% | 3 |
|
|
2025
Q1 | $46.3M | Hold |
12,674,120
| – | – | 19.62% | 2 |
|
|
2024
Q4 | $59.8M | Hold |
12,674,120
| – | – | 17.9% | 2 |
|
|
2024
Q3 | $118M | Hold |
12,674,120
| – | – | 19.94% | 2 |
|
|
2024
Q2 | $72.9M | Hold |
12,674,120
| – | – | 8.64% | 3 |
|
|
2024
Q1 | $85M | Hold |
12,674,120
| – | – | 5.58% | 4 |
|
|
2023
Q4 | $81.7M | Hold |
12,674,120
| – | – | 6.17% | 4 |
|
|
2023
Q3 | $63.4M | Hold |
12,674,120
| – | – | 4.6% | 3 |
|
|
2023
Q2 | $89.2M | Hold |
12,674,120
| – | – | 3.98% | 5 |
|
|
2023
Q1 | $78.6M | Hold |
12,674,120
| – | – | 3.05% | 5 |
|
|
2022
Q4 | $80.9M | Hold |
12,674,120
| – | – | 2.58% | 6 |
|
|
2022
Q3 | $109M | Hold |
12,674,120
| – | – | 4.58% | 5 |
|
|
2022
Q2 | $172M | Hold |
12,674,120
| – | – | 6.49% | 3 |
|
|
2022
Q1 | $193M | Hold |
12,674,120
| – | – | 4.53% | 4 |
|
|
2021
Q4 | $290M | Hold |
12,674,120
| – | – | 4.48% | 5 |
|
|
2021
Q3 | $177M | Hold |
12,674,120
| – | – | 1.85% | 5 |
|
|
2021
Q2 | $135M | Hold |
12,674,120
| – | – | 1.73% | 8 |
|
|
2021
Q1 | $167M | Hold |
12,674,120
| – | – | 2.68% | 7 |
|
|
2020
Q4 | $257M | Buy |
+12,674,120
| New | +$257M | 4.68% | 6 |
|